Merck seeks to halt Actavis from marketing generic version of NuvaRing

An article published by Bloomberg News on December 24 reported that drug maker Merck sued Actavis’ subsidiary Warner Chilcott in a federal court in Delaware over allegations that it attempted to sell a generic form of Merck’s NuvaRing bef…

Read More

Written by James H. Arenson

Last Updated : January 2, 2014